INTERNATIONAL PATENT: TAKEDA PHARMACEUTICAL COMPANY LIMITED FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR SPLICING MODULATION OF UNC13A"

GENEVA, Sept. 16 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1, Doshomachi 4-chomeChuo-ku, Osaka-shiOsaka, 541-0045) filed a patent application (PCT/IB2025/000078) for "COMPOSITIONS AND METHODS FOR SPLICING MODULATION OF UNC13A" on Mar 04, 2025. With publication no. WO/2025/186619, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MIYATA, Kenichi (c/o Takeda Pharmaceutical Company Limited26-1, Muraoka-Higashi 2-chomeFujisawa-shi, 251-0012), NOGAMI, Masahiro (c/o Takeda Pharmaceutical Company Limited26-1, Muraoka-Higashi 2-c...